Approvals/TGA/RIVASTIGMINE GxP PATCH 5 rivastigmine 4.6 mg/24 hours transdermal drug delivery system sachet

Approved

STANDARD

RIVASTIGMINE GxP PATCH 5 rivastigmine 4.6 mg/24 hours transdermal drug delivery system sachet

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: dfe77df0e7e7e4ee
Product Name: RIVASTIGMINE GxP PATCH 5 rivastigmine 4.6 mg/24 hours transdermal drug delivery system sachet
Artg Id: 233738
Artg Name: RIVASTIGMINE GxP PATCH 5 rivastigmine 4.6 mg/24 hours transdermal drug delivery system sachet
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2016-01-12
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

dfe77df0e7e7e4ee

Type

Standard